Drape Eric 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Feb 1, 2024

Insider Transaction Report

Form 4
Period: 2024-01-30
Drape Eric
Executive VP Global Operations
Transactions
  • Award

    Restricted Share Units

    2024-01-30+55,22655,226 total
    Ordinary Shares (55,226 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4